No shortage on file

CEFAZOLIN FOR INJECTION USP

SANDOZ CANADA INCORPORATED

Quick answers

Is there a shortage of CEFAZOLIN FOR INJECTION USP in Canada?

No. There is no current shortage of CEFAZOLIN FOR INJECTION USP 500MG reported to Health Canada. Stock can still vary from one pharmacy to another.

Can I still get this?No shortage reported — confirm local stock with your pharmacy

StatusNo shortage on file

Same-ingredient products on file6 products

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

KEFZOL ADD-VANTAGE INJ 500MG/VIAL

ELI LILLY CANADA INC

500MG · DIN 00411434

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

ANCEF INJ PWS 500MG/VIAL USP

SMITHKLINE BEECHAM PHARMA DIVISION OF SMITHKLINE BEECHAM INC

500MG · DIN 01919636

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

KEFZOL

PHARMACEUTICAL PARTNERS OF CANADA INC

10G · DIN 00411450

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

KEFZOL ADD-VANTAGE INJ 1GM/VIAL

ELI LILLY CANADA INC

1G · DIN 00411442

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

CEFAZOLIN FOR INJECTION

TEVA CANADA LIMITED

1G · DIN 02108127

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

ANCEF INJ PWS 10GM/VIAL USP

SMITHKLINE BEECHAM PHARMA DIVISION OF SMITHKLINE BEECHAM INC

10G · DIN 01919628

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

⚠ Possible Recall or Safety Alert

Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.

CEFAZOLIN FOR INJECTION USP 10 G / VIAL

CEFAZOLIN FOR INJECTION : Vials may be underfilled in the affected lot.

Type I2026-02-18

Highest health risk

Possible match — not confirmed

CEFAZOLIN FOR INJECTION, USP

Cefazolin for Injection: Affected lots are packaged with the incorrect Linear barcode on inner and outer bag labels.

Type III2026-02-09

Low health risk

Possible match — not confirmed

DIN

02308932

Strength

500MG

Dosage Form

Powder For Solution

Route

Intramuscular Intravenous

Active Ingredient

CEFAZOLIN (CEFAZOLIN SODIUM)

See all CEFAZOLIN (CEFAZOLIN SODIUM) products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

No shortage or discontinuation reports on file for this product.

Other Products from SANDOZ CANADA INCORPORATED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETYLCYSTEINE SOLUTION

200MG · DIN 02243098

ACLASTA

5MG · DIN 02269198

ALFENTANIL INJECTION USP

500MCG · DIN 02248181

AMIKACIN SULFATE INJECTION USP

250MG · DIN 02242971

AMIODARONE HYDROCHLORIDE FOR INJECTION

50MG · DIN 02242325

AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION

DIN 02495910